Wynclark Pharmaceuticals Private Limited

Sells medicines and general items, incorporated in 2007, based in Hyderabad.

2007 | Rangareddy, Telangana (India) | Active
Last Updated:

Wynclark Pharmaceuticals Profile

Key Indicators

  • Authorised Capital ₹ 14.08 Cr
  • Paid Up Capital ₹ 14.08 Cr
  • Company Age 18 Year, 3 Months
  • Last Filing with ROC 31 Mar 2024
  • Revenue Growth 40.13%
  • Profit Growth 24.69%
  • Ebitda 50.81%
  • Net Worth 61.48%
  • Total Assets 17.67%

About Wynclark Pharmaceuticals

Wynclark Pharmaceuticals Private Limited (WPPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 08 February 2007 and has a history of 18 years and three months. Its registered office is in Rangareddy, Telangana, India.

The Corporate was formerly known as Medplus Pathlabs Private Limited. The Company is engaged in the Pharma Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 14.08 Cr and a paid-up capital of Rs 14.08 Cr, as per Ministry of Corporate Affairs (MCA) records.

The Key Managerial Personnel (KMP) at Wynclark Pharmaceuticals Private Limited India are Sujit Mahato as CFO and Riti Gupta as Company Secretary. Satya Kammila, Bhaskar Cherukupalli, and Paidiwar Srinivas serve as directors at the Company.

Company Details

  • Location

    Rangareddy, Telangana, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

  • Social Media

Corporate Identity Details

  • CIN/LLPIN

    U24239TG2007PTC052676

  • Company No.

    052676

  • Company Classification

    Private Limited Indian Non-Government Company

  • Incorporation Date

    08 Feb 2007

  • Date of AGM

    10 Jul 2024

  • Date of Balance Sheet

    31 Mar 2024

  • Listing Status

    Unlisted

  • ROC Code

    Roc Hyderabad

Industry

Pharma
Company report

Wynclark Pharmaceuticals Private Limited

Explore comprehensive data for Wynclark Pharmaceuticals Private Limited, including financials, compliance details, shareholding patterns, and litigation history.

Who are the key members and board of directors at Wynclark Pharmaceuticals?

Executive Team (2)

NameDesignationAppointment DateStatus
Sujit Mahato Country flag representing In CFO16-Nov-2022Current
Riti Gupta Company Secretary10-Jan-2023Current

Board Members (3)

NameDesignationAppointment DateStatus
Satya Kammila Country flag representing In Whole-Time Director 29-Sep-2021Current
Bhaskar Cherukupalli Country flag representing In Director 29-Sep-2021Current
Paidiwar Srinivas Country flag representing In Director 03-Aug-2013Current

Financial Performance of Wynclark Pharmaceuticals.

Wynclark Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 40.13% increase. The company also saw a substantial improvement in profitability, with a 24.69% increase in profit. The company's net worth Soared by an impressive increase of 61.48%.

Wynclark Pharmaceuticals revenue growth over time
Wynclark Pharmaceuticals profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
40.13%
Revenue from Operations
39.79%
Total Assets
17.67%
Profit or Loss
24.69%
Net Worth
61.48%
EBITDA
50.81%

What is the Ownership and Shareholding Structure of Wynclark Pharmaceuticals?

In 2023, Wynclark Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Placeholder for charges-related data

There are no open charges registered against the company as per our records.

How Many Employees Work at Wynclark Pharmaceuticals?

Wynclark Pharmaceuticals has a workforce of 7 employees as of Apr 10, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee growth trends for Wynclark Pharmaceuticals Private Limited

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Wynclark Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Wynclark Pharmaceuticals's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Wynclark Pharmaceuticals

Recent activity within the organization

  • Annual General Meeting

    Wynclark Pharmaceuticals Private Limited last Annual general meeting of members was held on 10 Jul 2024 as per latest MCA records.

  • Balance Sheet

    Wynclark Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad.

  • Director Appointment

    Riti Gupta was appointed as a Company Secretary was appointed as a Company Secretary on 10 Jan 2023 & has been associated with this company since 2 years 4 months .

  • Director Appointment

    Sujit Kumar Mahato was appointed as a Cfo was appointed as a Cfo on 16 Nov 2022 & has been associated with this company since 2 years 6 months .

  • Director Appointment

    Satya Murali Krishna Kammila was appointed as a Whole-Time Director was appointed as a Whole-Time Director on 29 Sep 2021 & has been associated with this company since 3 years 7 months .

  • Director Appointment

    Bhaskar Reddy Cherukupalli was appointed as a Director was appointed as a Director on 29 Sep 2021 & has been associated with this company since 3 years 7 months .

Frequently asked questions

  • What is the Incorporation or founding date of Wynclark Pharmaceuticals Private Limited?

    Wynclark Pharmaceuticals Private Limited was incorporated on 08 Feb 2007.

  • What is authorized share capital and paid-up capital of Wynclark Pharmaceuticals Private Limited?

    The authorized share capital of Wynclark Pharmaceuticals Private Limited is ₹ 14.08 Cr and paid-up capital is ₹ 14.08 Cr.

  • Who are the current board members & directors of Wynclark Pharmaceuticals Private Limited?

    Currently 5 directors are associated with Wynclark Pharmaceuticals Private Limited.

    • Satya Murali Krishna Kammila
    • Sujit Kumar Mahato
    • Riti Gupta
    • Bhaskar Reddy Cherukupalli
    • Paidiwar Srinivas

  • What is the registered address of Wynclark Pharmaceuticals Private Limited?

    As per Ministry of Corporate Affairs (Mca), the registered address of Wynclark Pharmaceuticals Private Limited is Ground Floor 12-7-20/64/2 Survey No. 793 Goods Shed Road Moosapet Kukatpally, India, Hyderabad, Telangana, 500018.

  • What is the corporate identification number (CIN) and company number of Wynclark Pharmaceuticals Private Limited?

    The corporate identification number (CIN) of Wynclark Pharmaceuticals Private Limited is U24239TG2007PTC052676 and the company number is 052676 as per Ministry of Corporate Affairs (MCA).

  • What has been the recent revenue trend for Wynclark Pharmaceuticals Private Limited?

    According to the financial reports for the fiscal year 2023, the revenue trend for Wynclark Pharmaceuticals Private Limited has risen by 40.13%.

  • How many employees does Wynclark Pharmaceuticals Private Limited currently have?

    As Per 2023 financial reports, 7 employees are currently employed by Wynclark Pharmaceuticals Private Limited.

  • What change has been observed in the net worth of Wynclark Pharmaceuticals Private Limited, and by what percentage?

    The financial reports for the fiscal year 2023 indicates that The net worth of Wynclark Pharmaceuticals Private Limited has experienced an upsurge of 61.48%.

  • When was the last Balance Sheet of Wynclark Pharmaceuticals Private Limited filed with the ROC?

    The most recent Balance Sheet for Wynclark Pharmaceuticals Private Limited was filed with the ROC on 31 Mar 2024.

Unlock Business Insights – Explore Instantly!

Search company & director profiles for free and gain access to critical business data.

  • 3.1M+ Companies
  • 15M+ Legal Cases
  • 525K+ Credit Ratings
  • 5.8M+ Directors & KMP
  • 750K+ Regulatory Alerts
  • 1.1M+ Companies' Financial Records
Start Free Trial

People also Viewed

Similar Companies Based on Pharmaceutical Retailers & Distributors